Research Opportunity: DNA-Protein Epigenetic Chemistry Engineering (D-PECHE)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
DARPA is seeking innovative proposals aimed at developing and demonstrating proof-of-concept technologies for writing and erasing epigenetic base modifications in DNA. These mechanisms are intended to advance the ability to control DNA-protein interactions and enable exploration of rare or novel epigenetic modifications, which could have significant implications for understanding and manipulating nucleic acids. The research is focused on producing novel in vitro methods that effectively modify the epigenome. This special notice, titled "Research Opportunity: DNA-Protein Epigenetic Chemistry Engineering (D-PECHE)," was posted on May 6, 2026, with a response deadline of June 24, 2026. The solicitation number is DARPA-SN-26-67 and it falls under the NAICS code 541714. The effort is coordinated by the Department of Defense through the Defense Advanced Research Projects Agency, specifically the Biological Technologies Office located in Arlington, Virginia. Interested parties can contact Dr. Aric Lu at DARPA via email for further information. The opportunity emphasizes cutting-edge bioengineering challenges with potential broad impacts on epigenetics and molecular biology tools.
General Info
Agency
NAICS
Place of Performance
VASet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals to demonstrate proof-of-concept for novel mechanisms for writing and erasing epigenetic base modifications in DNA. Mechanisms capable of modifying the epigenome offer new opportunities to control DNA-protein interactions and to study the functions and applications of rare or novel epigenetic modifications. This research opportunity will result in demonstrations of novel technologies to modify nucleic acids in vitro.
